Overview
The life sciences industry is characterized, in large part, by unending innovation driven by the constant demand for new medical therapies. It is equally characterized by a robust but evolving regulatory framework in which the development of new technologies tends to outpace the laws needed to govern them.
In such a dynamic environment dominated by compliance issues and enforcement concerns, savvy legal advice is essential to an organization’s success.
At Epstein Becker Green, we have a tight-knit team of life sciences attorneys and advisors with strong backgrounds in science, industry, and government. Our clients are often on the leading edge of new technologies, and they trust us to guide them in areas where the regulatory picture remains unclear. We help them understand the law and its practical implications so they can adopt workable approaches to their legal, regulatory, and business issues.
Navigating the Regulatory Landscape
In an industry where stringent compliance obligations accompany every facet of a product’s development and commercialization, few companies can navigate the regulatory landscape without help. Our clients look to us to devise an overall regulatory strategy for their product, and we work with them to decide how that strategy will be implemented. How and by whom will the therapy be used? What research will be needed? What claims will need substantiating? What reimbursement schemes make the most sense? The answers to such questions—and countless similar ones—form the basis of each application for regulatory approval and provide our clients with roadmaps for addressing compliance issues going forward.
Our deep understanding of the applicable regulatory bodies and their enforcement mechanisms is key to every aspect of our client service. We represent clients in front of all such bodies, both in routine matters and in investigative inquiries. Our lawyers advise them on the development of their manufacturing and distribution systems. We arrange contracts defining their relationships with customers, vendors, and payors. We review their pricing options and sign off on advertising and promotional communications. Each of these efforts—and much more—is designed to ensure that all operations are fully optimized from both a business and a regulatory standpoint.
Serving Our Clients
Our team of life sciences attorneys and advisors serves organizations across the length and breadth of the life sciences industry, including:
- Academic centers
- Artificial intelligence companies
- Biotechnology companies
- Clinical laboratories
- Combination product manufacturers
- Digital health (IoT) companies
- Food and Dietary Supplements
- Genetics and Genomics
- Human cellular and tissue products (HCT/P) manufacturers
- In vitro diagnostic innovators
- Investors in the life sciences industry
- Medical device manufacturers
- Pharmaceutical and biologic manufacturers
- Precision medicine laboratories
- Research institutions and investigators
- Research services vendors (including contract research organizations and site management organizations
- Suppliers and distributors
- Telehealth companies
- Trade associations and industry coalitions
We cover a broad scope of products and services that fall within these general categories: research and development, clinical research support, product commercialization, FDA regulatory strategy, compliance and training, litigation, and transactions and capitalization.
Read less
Focus Areas
Services
- Academic and Clinical Research
- ADA and Public Accommodations
- Affirmative Action/OFCCP Compliance
- Appellate
- Business Torts, Competition & Trade Secrets
- Class Actions
- Commercial and Contract Litigation
- Corporate & Transactional
- Corporate and Securities Litigation
- Corporate Compliance Program Development, Implementation, and Effectiveness
- Corporate Financing
- Corporate Governance
- Corporate Reorganization
- Cross-Border Data Transfers
- Cross-Border Transactions
- Cybersecurity Risk Assessment
- Data Asset Management
- Data Breach and Incident Response
- Data Breach/Cybersecurity Investigations & Litigation
- Data Protection
- DEI Compliance and Legal Counseling
- Dietary Supplement Litigation
- Digital Health
- Drug and Medical Device Coding, Coverage, and Payment
- Drug and Medical Device Distribution
- Drug and Medical Device Litigation
- Drug Pricing Policy & Reporting
- Employee Benefits and ERISA
- Employment Compliance Counseling
- Employment Litigation
- Employment Training
- Employment, Labor & Workforce Management
- ERISA – Retirement and Benefit Plan Litigation
- Executive Compensation
- FDA Inspections and Enforcement
- Federal Research Grants: Compliance, Investigations & Enforcement
- Financial Restructuring and Bankruptcy
- Foreign Multinational Counseling and Litigation
- General Counsel Services
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Care and Life Sciences Investor Services
- Health Policy and Legislation
- Immigration
- Industry Research and Clinical Trials
- Insider Threats
- Intellectual Property
- Intellectual Property Litigation
- Internet of Things (IoT)
- Labor and Employment Due Diligence
- Labor Management Relations
- Life Sciences
- Life Sciences Due Diligence
- Litigation & Business Disputes
- Mergers, Acquisitions & Divestitures
- Occupational Safety and Health (OSHA)
- Pandemic Workforce Issues
- Pay Equity
- Privacy Compliance Strategies
- Privacy, Cybersecurity & Data Asset Management
- Product Marketing and Compliance
- Ransomware
- Real Estate
- Regulatory Strategy, Product Development, and Product Approvals
- Remote and Hybrid Work
- Social Media and the Workplace
- State Privacy Law Compliance
- Tax and Tax-Exempt Counseling
- Trade Secrets & Employee Mobility
- Wage and Hour
- Whistleblowing and Compliance
- White Collar Defense and Internal Investigations
- Workforce Government Relations
- Workforce Restructuring and Other Cost-Saving Mechanisms
- Workplace Investigations
Industries
Experience
Our Team
Media
Events
Upcoming Events
- July 24 - 25, 2025
Past Events
Insights
Insights
- BlogsSpilling Secrets Podcast: Trade Secrets on Trial - Strategic Decisions for the Courtroom2 minute read
- Media CoverageRichard Hughes Quoted in “States Loosen Vaccine Rules — Even as Measles Outbreak Rages”8 minute read
- Media Coverage
Richard Hughes Featured in Healthcare Matters, “Immunization at a Crossroads: Experts Weigh In from the World Vaccine ...
4 minute read - Media CoverageFrank Morris Quoted in “Trump Disparate Impact Order Shifts Agency Civil Rights Mission”2 minute read
- BlogsVideo: Federal Court Strikes Down FDA Rule on LDTs – Thought Leaders in Health Law2 minute read
- Media CoverageRichard Hughes Quoted in “Kennedy Issues Demands for Vaccine Approvals That Could Affect Fall Covid Boosters” ...2 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr.’s Latest Vaccine Plan Threatens Future of Shots, Experts Say”2 minute read
- PublicationsNewborn Screening at Risk: Implications of Disbanding the Advisory Committee on Heritable Disorders in Newborns and ...2 minute read
- BlogsVideo: 100 Days In - What Employers Need to Know - Employment Law This Week3 minute read
- PublicationsNew Executive Order Addresses Disparate Impact Liability: Key Implications for Employers13 minute read
- Firm AnnouncementsEpstein Becker Green’s Dedicated Support of AHLA Earns 2025 Top Honors Recognition2 minute read
- PublicationsThe Future of Preventive Care Depends on the Supreme Court’s Reading of Two Words2 minute read
- Media CoverageMarc Mandelman Quoted in “The Latest Blow to Civil Rights in the Workplace”4 minute read
- Media CoverageRichard Hughes Quoted in “SCOTUS Weighing Braidwood Appointments Clause Violation in Briefs Request”2 minute read
- Media CoverageRichard Hughes Quoted in “Survival of Preventive Care Coverage Mandate Would Boost Some Health Care Firms”2 minute read
- Media CoverageRichard Hughes Quoted in “Why Journalists Need to Explain the Value of No-Cost Preventive Care”7 minute read
- Media CoverageRichard Hughes Quoted in “Experts: Look to States and the Courts for Shifts in Vaccine Policy”5 minute read
- BlogsPodcast: Breaking Down the Shifting Vaccine Policy Landscape – Diagnosing Health Care2 minute read
- BlogsVideo: Non-Competes Eased, Anti-DEI Rule Blocked, Contractor Rule in Limbo - Employment Law This Week3 minute read
- Blogs
Aligning Business Goals with Legal Strategies Amid Regulatory Change – Speaking of Litigation Video Podcast
41 minute read - Media CoverageWilliam Walters Quoted in “Ruling Could Give Kennedy More Power Over Health Care Coverage”4 minute read
- Media CoverageRichard Hughes Quoted in “ACA Preventive Care Case Reaches Supreme Court”4 minute read
- Media Coverage
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A with Richard Hughes, IV
4 minute read - Media CoverageRichard Hughes Quoted in “Supreme Court Grapples with Challenge to ObamaCare Preventive Care Panel”6 minute read
- Media CoverageWilliam Walters Quoted in “Supreme Court Appears Willing to Save ACA Preventive Services Task Force”3 minute read
- PublicationsSolving the EDDO Guidance Puzzle1 minute read
- BlogsInsider Strategies for Wage and Hour Compliance Success: One-on-One with Paul DeCamp2 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Hear Challenge to Obamacare Rule on Free Preventive Care”4 minute read
- BlogsNew York State Proposes Bill to Ban Noncompetes Except for Highly Compensated Workers and in Sales of Businesses ...6 minute read
- Media CoverageRichard Hughes Quoted in “‘At the Mercy of Insurance Companies’: Supreme Court Braces for ACA Preventive Coverage ...4 minute read
- Media CoverageRichard Hughes Quoted in “RFK Jr. Attacks Environmental Toxins as Cause of Childhood Autism 'Epidemic', Stays Silent on ...8 minute read
- Media CoverageRichard Hughes Quoted in “On Autism, Experts Worry Kennedy May Pivot Back to Vaccine Claims”2 minute read
- PublicationsPutting Price Transparency into Perspective2 minute read
- BlogsVideo: Can the President Fire NLRB Members Without Cause? SCOTUS May Decide - Employment Law This Week3 minute read
- BlogsTexas Joins List of Legislatures Seeking to Ban Noncompete Agreements4 minute read
- Media CoverageJames Boiani Quoted in “Will Trump Admin. ‘Wash Its Hands’ of FDA Lab-Test Rule?”2 minute read
- Media CoverageHelaine Fingold Quoted in “'Watching the Clues': Uncertainty Clouds Medicare Broker Conference”3 minute read
- Media CoverageRichard Hughes Quoted in “States Echo RFK Jr. Agenda in Push for Ban on Vaccine Mandates”2 minute read
- PublicationsVaccine Advisory Committee Meetings Resume: What Lies Ahead?3 minute read
- BlogsPodcast: Executive Actions Impact Federally Funded Research - What Institutions Should Do Now – Diagnosing Health Care2 minute read
- Media CoverageRichard Hughes Quoted in “Idaho Restricts Vaccine Mandates”3 minute read
- BlogsVideo: Artificial Intelligence Regulations for Employers - Employment Law This Week3 minute read
- PublicationsThe LDT Final Rule Bites the Dust: Examining the Repercussions of the Federal Court’s Vacatur and What the Future May Hold ...16 minute read
- PublicationsCTA Interim Final Rule Eliminates Requirements for U.S. Companies and U.S. Individuals to File Beneficial Ownership ...3 minute read
- BlogsCourt Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS ...10 minute read
- Media CoverageJames Boiani Quoted in “Drug Industry Worries About FDA Delays”3 minute read
- Media CoverageRob Wanerman Quoted in “HHS Reorganization Raises Questions for Claims Appeals Process”1 minute read
- BlogsVideo: EEOC/DOJ Joint DEI Guidance, EEOC Letters to Law Firms, OFCCP Retroactive DEI Enforcement - Employment Law This Week3 minute read
- Media CoverageRichard Hughes Quoted in “Supreme Court to Weigh Medicaid Cutoff for Planned Parenthood”2 minute read
- BlogsA Final Rule Bites the Dust: Federal Court Rules FDA Lacks Authority to Regulate LDTs2 minute read